Alirocumab Biosimilar - Anti-PCSK9 mAb - Research Grade
Source
CAS 1245916-14-6
Species
Homo sapiens
Expression system
Mammalian cells
Molecular weight
146kDa
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Alirocumab,REGN727,SAR-236553,PCSK9,anti-PCSK9
Reference
PX-TA1287
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG1-kappa
Clonality
Monoclonal Antibody
Description of Alirocumab Biosimilar - Anti-PCSK9 mAb - Research Grade
General information on Anti-PCSK9[Homo sapiens] (Alirocumab) Monoclonal Antibody
Alirocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia.
Reviews
There are no reviews yet.